FATE Therapeutics Inc
FATEAs of the close on Sep 25, 2026
Price
$2.35
Market cap
$282M
P/E (diluted TTM)
—
Not meaningful: the last four quarters were a loss
EPS (TTM)
−$1.05
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How FATE Therapeutics Inc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 15 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 15, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Bank of New York Mellon Corp | 2026-03-31 | 306,987 | $368K | SEC filing |
| RENAISSANCE TECHNOLOGIES LLC | 2026-03-31 | 2,974,683 | $3.57M | SEC filing |
| ProShare Advisors LLC | 2026-03-31 | 15,764 | $18.9K | SEC filing |
| Quadrature Capital Ltd | 2026-03-31 | 120,343 | $144K | SEC filing |
| Caitong International Asset Management Co., Ltd | 2026-03-31 | 1 | $1 | SEC filing |
| Fortitude Family Office, LLC | 2026-03-31 | 427 | $512 | SEC filing |
| NISA INVESTMENT ADVISORS, LLC | 2026-03-31 | 1,331 | $1.6K | SEC filing |
| Privium Fund Management B.V. | 2026-03-31 | 414,311 | $497K | SEC filing |
| GSA CAPITAL PARTNERS LLP | 2026-03-31 | 298,881 | Not shown | SEC filing |
| Physician Wealth Advisors, Inc. | 2026-03-31 | 1,094 | $1.31K | SEC filing |
| Graham Capital Management, L.P. | 2026-03-31 | 64,766 | $77.7K | SEC filing |
| National Philanthropic Trust | 2026-03-31 | 125,000 | $150K | SEC filing |
| Focus Partners Advisor Solutions, LLC | 2026-03-31 | 15,221 | $18.3K | SEC filing |
| Caitlin John, LLC | 2026-03-31 | 40 | $48 | SEC filing |
| Woodline Partners LP | 2026-03-31 | 238,650 | $286K | SEC filing |
| SBI Securities Co., Ltd. | 2026-03-31 | 1,172 | $1.41K | SEC filing |
| Hilltop National Bank | 2026-03-31 | 285 | $342 | SEC filing |
| SCHULHOFF & CO INC | 2026-03-31 | 100,000 | $120K | SEC filing |
| Sunbelt Securities, Inc. | 2026-03-31 | 91 | $109 | SEC filing |
| Wealth Preservation Advisors, LLC | 2026-03-31 | 309 | $371 | SEC filing |
- Each value is checked against FATE Therapeutics Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at FATE Therapeutics Inc's share price.
120 filers have only one report here.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-20 | Valamehr Bahram · President and CEO | Common Stock | S — Open market or private sale | −28,946 | 1.88 | SEC filing |
| 2026-05-20 | TAHL CINDY · See Remarks | Common Stock | S — Open market or private sale | −25,590 | 1.88 | SEC filing |
| 2026-01-09 | Valamehr Bahram · President and CEO | Common Stock | S — Open market or private sale | −5,190 | 1.07 | SEC filing |
| 2026-01-09 | TAHL CINDY · See Remarks | Common Stock | S — Open market or private sale | −10,589 | 1.06 | SEC filing |
| 2025-08-04 | Valamehr Bahram · President and CEO | Common Stock | S — Open market or private sale | −14,466 | 1.06 | SEC filing |
| 2025-08-04 | TAHL CINDY · See Remarks | Common Stock | S — Open market or private sale | −9,037 | 1.06 | SEC filing |
| 2025-01-10 | TAHL CINDY · See Remarks | Common Stock | S — Open market or private sale | −5,654 | 1.55 | SEC filing |
| 2025-01-10 | Valamehr Bahram · President and CEO | Common Stock | S — Open market or private sale | −8,705 | 1.54 | SEC filing |
Showing 8 of 17 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-12 | RASTETTER WILLIAM H · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +87,900 | SEC filing |
| 2026-06-12 | Lee Michael Stewart · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +87,900 | SEC filing |
| 2026-06-12 | ABERNETHY MATT · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +87,900 | SEC filing |
| 2026-06-12 | EPSTEIN ROBERT S · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +87,900 | SEC filing |
| 2026-06-12 | Redmile Group, LLC · Director, 10% owner | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +87,900 | SEC filing |
| 2026-06-12 | Jooss Karin · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +87,900 | SEC filing |
| 2026-06-12 | Hamill Laura · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +175,800 | SEC filing |
| 2026-06-12 | Xu Yuan · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +87,900 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-04-20 | Redmile Group, LLC · Director, 10% owner | Common Stock | J — Other acquisition or disposition | −8,977,624 | SEC filing |
| 2026-04-20 | Redmile Group, LLC · Director, 10% owner | Pre-Funded Warrants to Purchase Common Stock | J — Other acquisition or disposition | +3,691,324 | SEC filing |
| 2026-04-20 | Redmile Group, LLC · Director, 10% owner | Common Stock | J — Other acquisition or disposition | +8,977,624 | SEC filing |
| 2026-04-20 (amended) | Redmile Group, LLC · Director, 10% owner | Cash-settled Swaps | J — Other acquisition or disposition | +266,280 | SEC filing |
| 2026-04-20 | Redmile Group, LLC · Director, 10% owner | Class A Convertible Preferred Stock | J — Other acquisition or disposition | +162,013 | SEC filing |
| 2026-04-20 (amended) | Redmile Group, LLC · Director, 10% owner | Cash-settled Swaps | J — Other acquisition or disposition | −266,280 | SEC filing |
| 2026-04-20 | Redmile Group, LLC · Director, 10% owner | Pre-Funded Warrants to Purchase Common Stock | J — Other acquisition or disposition | −3,691,324 | SEC filing |
| 2026-04-20 | Redmile Group, LLC · Director, 10% owner | Class A Convertible Preferred Stock | J — Other acquisition or disposition | −162,013 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.